Frontiers in Oncology (Jun 2021)
Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells
- Shenq-Shyang Huang,
- Shenq-Shyang Huang,
- Wen-Ying Liao,
- Chung-Chi Hsu,
- Tze-Sian Chan,
- Tze-Sian Chan,
- Tze-Sian Chan,
- Tai-Yan Liao,
- Pei-Ming Yang,
- Li-Tzong Chen,
- Li-Tzong Chen,
- Shian-Ying Sung,
- Kelvin K. Tsai,
- Kelvin K. Tsai,
- Kelvin K. Tsai,
- Kelvin K. Tsai,
- Kelvin K. Tsai,
- Kelvin K. Tsai
Affiliations
- Shenq-Shyang Huang
- Graduate Program of Biotechnology in Medicine, Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu, Taiwan
- Shenq-Shyang Huang
- Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Wen-Ying Liao
- Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Chung-Chi Hsu
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
- Tze-Sian Chan
- Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Tze-Sian Chan
- Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
- Tze-Sian Chan
- Integrated Therapy Center for Gastroenterological Cancers, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
- Tai-Yan Liao
- Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Pei-Ming Yang
- Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
- Li-Tzong Chen
- National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
- Li-Tzong Chen
- Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
- Shian-Ying Sung
- The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
- Kelvin K. Tsai
- Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- Kelvin K. Tsai
- Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
- Kelvin K. Tsai
- Integrated Therapy Center for Gastroenterological Cancers, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
- Kelvin K. Tsai
- National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
- Kelvin K. Tsai
- 0Clinical Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
- Kelvin K. Tsai
- 1Taipei Medical University (TMU) and Affiliated Hospitals Pancreatic Cancer Groups, Taipei Medical University, Taipei, Taiwan
- DOI
- https://doi.org/10.3389/fonc.2021.718849
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords